| Adaptive designs in clinical trials: why use them, and how to run and report them |
65 |
| Key challenges for delivering clinical impact with artificial intelligence |
65 |
| The Health Stigma and Discrimination Framework: a global, crosscutting framework to inform research, intervention development, and policy on health-related stigmas |
63 |
| Celiac disease: a comprehensive current review |
62 |
| When complexity science meets implementation science: a theoretical and empirical analysis of systems change |
58 |
| Recent advances in triple negative breast cancer: the immunotherapy era |
57 |
| Challenges and opportunities in examining and addressing intersectional stigma and health |
47 |
| How and why weight stigma drives the obesity 'epidemic' and harms health |
46 |
| Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatmentsa WWARN individual patient data meta-analysis |
45 |
| Stigma in health facilities: why it matters and how we can change it |
44 |
| Utility of circulating tumor DNA in cancer diagnostics with emphasis on early detection |
42 |
| The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review |
41 |
| Gestational weight gain across continents and ethnicity: systematic review and meta-analysis of maternal and infant outcomes in more than one million women |
38 |
| ApoE4: an emerging therapeutic target for Alzheimer's disease |
37 |
| Are dementia with Lewy bodies and Parkinson's disease dementia the same disease? |
36 |
| Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin |
33 |
| From hype to reality: data science enabling personalized medicine |
32 |
| The implications of three major new trials for the effect of water, sanitation and hygiene on childhood diarrhea and stunting: a consensus statement |
31 |
| Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts |
31 |
| Fit-for-purpose?' - challenges and opportunities for applications of blockchain technology in the future of healthcare |
29 |
| Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic? |
29 |
| A systematic review of multi-level stigma interventions: state of the science and future directions |
29 |
| Calibration: the Achilles heel of predictive analytics |
28 |
| Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017 |
27 |
| The association of depression and all-cause and cause-specific mortality: an umbrella review of systematic reviews and meta-analyses |
27 |
| The epidemiological burden of obesity in childhood: a worldwide epidemic requiring urgent action |
26 |
| Knowledge translation in health: how implementation science could contribute more |
26 |
| Identifying older adults at risk of harm following elective surgery: a systematic review and meta-analysis |
24 |
| Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial |
24 |
| Tobacco smoking and risk of 36 cardiovascular disease subtypes: fatal and non-fatal outcomes in a large prospective Australian study |
23 |
| A cut-off of daily sedentary time and all-cause mortality in adults: a meta-regression analysis involving more than 1 million participants |
23 |
| Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study |
23 |
| A scoping review of health-related stigma outcomes for high-burden diseases in low- and middle-income countries |
23 |
| Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review |
22 |
| Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease |
21 |
| Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births |
21 |
| A longitudinal, observational study of the features of transitional healthcare associated with better outcomes for young people with long-term conditions |
21 |
| Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort |
19 |
| Measuring and mapping the global burden of antimicrobial resistance |
19 |
| Prospective association between ultra-processed food consumption and incident depressive symptoms in the French NutriNet-Sante cohort |
19 |
| Effects of school neighborhood food environments on childhood obesity at multiple scales: a longitudinal kindergarten cohort study in the USA |
19 |
| The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort |
19 |
| Built environmental characteristics and diabetes: a systematic review and meta-analysis |
19 |
| Musculoskeletal conditions may increase the risk of chronic disease: a systematic review and meta-analysis of cohort studies |
18 |
| Perinatal health outcomes and care among asylum seekers and refugees: a systematic review of systematic reviews |
18 |
| A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo |
17 |
| Comparison of statins for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis |
17 |
| Simple rules for evidence translation in complex systems: A qualitative study |
17 |
| Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement |
16 |
| Sleep deficiency and motor vehicle crash risk in the general population: a prospective cohort study |
16 |
